Amplifying antigen-induced cellular responses with proximity labelling

Shuojun Li1, Yinghui Men1,2, Zihan Wang1

  • 1Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Key Laboratory of RNA Innovation Science and Engineering, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.

Nature
|September 10, 2025
PubMed

Insights

Researchers developed a novel proximity-labeling technology to amplify synthetic antigen clusters on cell surfaces. This method enhances T-cell activation and triggers potent anti-tumor immune responses, leading to tumor eradication and long-term immunity.

Area of Science:

  • Immunology
  • Biochemistry
  • Molecular Biology

Background:

  • Antigen-induced receptor clustering is crucial for cell signaling but often limited by low antigen density.
  • Naturally occurring antigens, like tumor-associated antigens, may not induce sufficient receptor clustering for robust immune responses.

Purpose of the Study:

  • To develop a proximity-labeling technology for amplifying synthetic antigen clusters on cell surfaces.
  • To enhance T-cell receptor (TCR) clustering and downstream signaling for improved anti-tumor immunity.

Main Methods:

  • Repurposed proximity labeling to create high-density fluorescein probe clusters near target antigens.
  • Developed in vivo proximity-labeling controlled by red light or ultrasound.
  • Utilized fluorescein-binding bispecific T-cell engagers to activate T-cells.

Main Results:

  • Amplified fluorescein clusters effectively engaged TCRs, enhancing T-cell activation and cytotoxicity.
  • Noninvasive, tissue-selective labeling in mouse tumor models led to rapid tumor eradication.
  • Induced epitope spreading, promoting systemic immunity and immunological memory.

Conclusions:

  • Proximity-labeling chemistry offers a versatile strategy to enhance antigen-dependent receptor function.
  • This approach can be generalized to manipulate cell states and immune responses.
  • The technology shows promise for cancer immunotherapy by amplifying immune cell activation against tumors.